Research
Peptide Guide.

Cycle length (research / real-world use)

Tirzepatide is NOT a cycle-based compound

How it’s actually used:

Designed for continuous, long-term treatment

Clinical trials typically run:

40–72 weeks+

Benefits accumulate over months, not weeks

Cycle length

Same principle again:

Semaglutide is NOT meant to be cycled

How it’s actually used:

Designed for continuous, long-term use

Clinical trials:

Typically 68 weeks+

Effects build gradually over months

Cycle length (research / real-world use)

Same key principle as the others:

Cagrilintide is NOT a cycle-based compound

In studies:

Used as continuous therapy

Trials typically run:

20–68 weeks+

Effects build gradually over time

What GHK-Cu is

A tripeptide + copper ion

Known for roles in:

skin regeneration

wound healing

collagen production

Widely used in cosmetics and dermatology research

What it’s studied for

Research suggests GHK-Cu may:

Stimulate collagen and elastin

Improve skin elasticity and wrinkles

Promote hair growth (early-stage evidence)

Support wound healing and tissue repair

Have anti-inflammatory and antioxidant effects

Possible Cycle:

12 weeks followed by 1-2 months off, or month on month off

What it’s studied for

Research commonly investigates:

skin regeneration and repair models

collagen and elastin production pathways

hair follicle stimulation mechanisms

wound healing and tissue remodeling

anti-inflammatory signalling effects

cosmetic and dermatological regenerative research

Cycle length (research / anecdotal use)

Common informal / experimental research patterns

4–12 weeks frequently discussed

sometimes used longer in regenerative or cosmetic research models

Typically explored as:

daily or near-daily administration in study designs

or periodic dosing depending on experimental goals

Theoretical research schedule examples

Low protocol:

= 5 units daily (≈0.33 mg)

Moderate protocol:

= 10 units daily (≈0.67 mg)

Higher research example:

= 15 units daily (≈1 mg)

Common research pairing

Often discussed alongside:

GHK-Cu

skin regeneration peptide protocols

hair follicle stimulation research compounds

extracellular matrix and collagen-support models

Due to overlapping copper-peptide signalling pathways involved in tissue repair and remodeling.

What it’s studied for

Research areas include:

muscle and tendon healing

ligament recovery

wound healing

inflammation reduction

possible cardiac repair effects

Cycle length” (research / anecdotal use)

1. “Loading phase”

~2–6 weeks

Higher frequency dosing

2. “Maintenance phase”

Additional weeks or intermittent use

Typical total duration discussed:

4–12 weeks

What it’s studied for

Research suggests potential effects on:

tendon and ligament healing

muscle repair

gut lining protection (ulcers, inflammation)

nerve healing

angiogenesis (blood vessel formation)

One unique angle

Strong focus on gut repair + systemic healing signaling

Cycle length” (research / anecdotal use)

Like TB-500:

Common informal/research-style use patterns:

Duration often discussed:

2–6 weeks (short protocols)

sometimes extended to 8–12 weeks

Used either:

continuously during that period

or until an injury “resolves”

What it’s studied for

Research suggests potential effects on:

gut inflammation modulation

intestinal barrier support

inflammatory signalling pathways

skin inflammation models

mucosal healing pathways

immune regulation mechanisms

One unique angle

Strong focus on local anti-inflammatory signalling + gastrointestinal support

Cycle length (research / anecdotal use)

Common informal / research-style use patterns

Duration often discussed:

2–4 weeks (short protocols)

sometimes extended to 6–8 weeks

Used either:

continuously during that period

or until research objective / endpoint is reached

Why they’re combined

The idea is “synergy”:

BPC-157:

targets connective tissue + gut + inflammation

TB-500:

enhances systemic healing + cell movement + blood flow

Together they:

hit multiple repair pathways at once

may improve:

muscle recovery

tendon/ligament healing

inflammation control

Cycle length

Like the individual peptides:

What’s commonly discussed (non-clinical):

Typical duration:

4–8 weeks

sometimes 6–12 weeks depending on injury severity

Often structured as:

continuous use during that period

then stop or reassess

Why they’re combined

The idea is “synergy”:

BPC-157:

targets connective tissue + gut + inflammation

TB-500:

enhances systemic healing + cell movement + blood flow

KPV:

targets connective tissue + gut + inflammation

Together they:

hit multiple repair pathways at once

may improve:

muscle recovery

tendon/ligament healing

inflammation control

Gut lining

Cycle length

Like the individual peptides:

What’s commonly discussed (non-clinical):

Typical duration:

4–8 weeks

sometimes 6–12 weeks depending on injury severity

Often structured as:

continuous use during that period

then stop or reassess

What it’s designed for (research context)

This blend is basically trying to stack three mechanisms at once:

Skin + cosmetic side (GHK-Cu)

collagen, elasticity, “glow”

Localized repair (BPC-157)

tendons, ligaments, gut

Systemic repair (TB-500)

blood flow, cell migration, recovery

In research, it’s explored for:

tissue regeneration

wound healing

inflammation modulation

skin biology / anti-aging pathways

Cycle length

What’s commonly discussed (non-medical / anecdotal):

4–8 weeks most typical

sometimes up to 12 weeks

From community discussion:

“cycle 4–5 weeks” (example anecdotal protocol)

The “cycle” is completely informal, not based on human trials.

What KPV adds

KPV (Lys-Pro-Val) is a small peptide fragment derived from alpha-MSH

It’s mainly studied for:

strong anti-inflammatory effects

immune modulation

gut inflammation (IBD-type models)

skin inflammation (acne, dermatitis models)

Adding KPV turns Glow into something more inflammation-focused:

Glow blend:

regeneration + skin + healing

Klow blend:

regeneration + skin + healing + inflammation control

The theoretical benefit:

better for:

irritated skin

chronic inflammation

gut + skin crossover issues

Cycle length

Common anecdotal ranges:

4–8 weeks typical

sometimes up to 10–12 weeks

What makes it interesting

Unlike GLP-1 drugs (semaglutide, tirzepatide):

Doesn’t suppress appetite directly

Works more on how your body uses energy

Think:

GLP-1s → “eat less”

MOTS-c → “use energy better”

Cycle length

2–4 weeks short protocols

sometimes 4–8 weeks

Often used:

daily or several times per week

sometimes around training periods

What it’s studied for

Research commonly investigates:

mitochondrial biogenesis pathways

endurance and exercise signalling

metabolic flexibility

fatty acid oxidation mechanisms

energy expenditure models

skeletal muscle metabolic activity

Cycle length (research / anecdotal use)

Common informal / experimental research discussions include

4–8 week exploratory protocols

variable schedules depending on metabolic research objectives

Often discussed in:

once-daily research models

endurance or recomposition-focused protocols

Theoretical research schedule examples

Low protocol:

= 5 units daily (≈170 mcg)

Moderate protocol:

= 10 units daily (≈330 mcg)

Higher research example:

= 15 units daily (≈500 mcg)

Common research pairing

Often discussed alongside:

mitochondrial-support research compounds

endurance-focused experimental protocols

metabolic and recomposition research models

Due to overlapping energy metabolism signalling interests.

What it’s studied for

Research commonly investigates:

mitochondrial bioenergetics

oxidative stress pathways

recovery and endurance signalling

cellular repair mechanisms

cardiac and skeletal muscle energy models

neuroprotective and metabolic research applications

Cycle length (research / anecdotal use)

Common informal / research-style discussions include

2–8 week protocols frequently discussed

sometimes extended in mitochondrial-focused research models

Often administered:

once daily

occasionally split into multiple administrations in experimental settings

Theoretical research schedule examples

Low protocol:

= 5 units daily (≈0.5 mg)

Moderate protocol:

= 10 units daily (≈1 mg)

Higher research example:

= 30 units daily (≈3 mg)

Common research pairing

Often discussed alongside:

mitochondrial-support compounds

endurance-focused research protocols

recovery and oxidative stress models

metabolic and cellular energy pathway research

Due to overlapping mitochondrial and bioenergetic signalling interests.

Components:

CJC-1295 (no DAC)

A modified version of **growth hormone-releasing hormone

Signals the pituitary to release GH

Ipamorelin

A ghrelin mimetic (growth hormone secretagogue)

Triggers GH release without strongly increasing cortisol or prolactin

Together:

They synergistically increase pulsatile GH release

Why they’re combined

Each peptide hits a different pathway:

CJC-1295 → increases baseline GH signaling

Ipamorelin → triggers GH pulses

Result:

more natural GH rhythm vs using either alone

often described as:

smoother

more physiological

Cycle length

But this combo is one of the more “structured” ones in peptide discussions.

Common informal protocols:

8–12 weeks typical

sometimes extended to:

12–16 weeks

Often followed by:

a break (e.g. 4 weeks)

Key point:

It triggers natural GH pulses rather than replacing GH directly

Ipamorelin is studied for:

increased growth hormone (GH) and IGF-1

improved recovery and repair

better sleep quality

potential fat loss (indirect)

mild support for lean mass

Effects are generally

subtle

gradual

dependent on consistency

Cycle length

Common informal / research-style use:

8–12 weeks typical

sometimes extended to:

12–16 weeks

Often followed by:

a break period (e.g. a few weeks)

What it’s studied for

Research interest commonly includes:

growth hormone signalling

IGF-1 modulation

recovery pathways

sleep quality mechanisms

lean tissue preservation

exercise recovery models

aging-related endocrine research

Cycle length (research / anecdotal use)

Common informal / research-style patterns

8–12 weeks is frequently discussed

sometimes extended longer in rotational protocols

Often administered:

once nightly

or split into multiple daily pulses in some research protocols

Theoretical research schedule examples

Low protocol:

= 5 units nightly (≈330 mcg)

Moderate protocol:

= 10 units nightly (≈670 mcg)

Higher research example:

= 15 units nightly (≈1 mg)

Common research pairing

Often discussed in combination with:

Ipamorelin

GHRP-class peptides

recovery-focused protocols

Due to complementary GH pulse signalling mechanisms.

What it’s studied for

Research commonly focuses on:

visceral fat reduction pathways

growth hormone signalling

IGF-1 modulation

metabolic regulation

recovery mechanisms

body composition research

cognitive and neuroprotective pathways

Cycle length (research / anecdotal use)

Common informal / research-style patterns

8–12 weeks frequently discussed

sometimes extended in longer metabolic research protocols

Often administered:

once daily

commonly in evening or fasted-state research protocols

Theoretical research schedule examples

Low protocol:

= 5 units nightly (≈330 mcg)

Moderate protocol:

= 10 units nightly (≈670 mcg)

Higher research example:

= 15 units nightly (≈1 mg)

Common research pairing

Often discussed alongside:

Ipamorelin

CJC-1295

metabolic-focused peptide protocols

recovery and recomposition research models

Due to complementary GH / IGF-1 pathway interest.

What it’s studied for

Research commonly investigates:

muscle cell growth signalling

recovery and regeneration pathways

nutrient partitioning mechanisms

insulin sensitivity interactions

tissue repair models

performance and hypertrophy research

cellular growth signalling

Cycle length (research / anecdotal use)

Common informal / research-style patterns

4–6 weeks frequently discussed

sometimes extended cautiously in longer protocols

Often administered:

once daily

commonly around training-window research protocols

Theoretical research schedule examples

Dosing thoery

= 10 units After training (≈33 mcg)

Common research pairing

Often discussed alongside:

CJC-1295

Ipamorelin

growth hormone secretagogues

recovery and hypertrophy-focused research protocols

Due to complementary anabolic signalling pathway interest.

Cycle length

4–8 weeks typical

sometimes extended to 8–12 weeks

Cycle length

10–20 days per cycle some extend to 30 days.

repeated:

1–2 times per year

Why people use it

anti-aging / longevity

improved sleep quality

circadian rhythm support

general “recovery” feeling

Cycle length

This one is different because it does have real clinical protocols.

In medical use:

Often used for:

several weeks to months

Example patterns:

6–12 weeks common

sometimes longer depending on condition

What it’s studied for

Research commonly investigates:

cancer-cell targeting mechanisms

membrane pore formation models

apoptosis and necrosis signalling pathways

HDM-2 interaction mechanisms

selective tumor-cell response models

experimental oncology applications

Cycle length (research / anecdotal use)

Common informal / experimental research-style discussions include

2–6 week exploratory protocols

variable schedules depending on research design

Administration frequency in discussions varies widely due to the experimental nature of the compound.

Theoretical research schedule examples

Low protocol:

= 5 units daily (≈170 mcg)

Moderate protocol:

= 10 units daily (≈330 mcg)

Higher research example:

= 15 units daily (≈500 mcg)

What it’s studied for

Research commonly investigates:

sleep quality pathways

recovery and relaxation signalling

stress modulation mechanisms

circadian rhythm regulation

neuroendocrine interactions

fatigue and recovery models

Cycle length (research / anecdotal use)

Common informal / research-style patterns

2–6 weeks frequently discussed

sometimes used intermittently based on sleep-focused protocols

Often administered:

nightly

typically prior to sleep-focused research periods

Theoretical research schedule examples

Low protocol:

= 5 units nightly (≈170 mcg)

Moderate protocol:

= 10 units nightly (≈330 mcg)

Higher research example:

= 15 units nightly (≈500 mcg)

Common research pairing

Often discussed alongside:

CJC-1295

Ipamorelin

recovery-focused peptide protocols

sleep and CNS-support research models

Due to overlapping recovery and restorative signalling interests.

Cycle length

TRT is NOT a cycle

This is the biggest difference from everything else you’ve asked about.

❌ Not 8–12 weeks

❌ Not on/off

✅ Long-term (often lifelong) therapy

TRT = continuous hormone replacement, not cycling

Stopping TRT:

testosterone levels drop back to baseline (often low again)

symptoms return

📊 Typical TRT dosing (medical context)

Usually:

100–200 mg per week

Injection frequency: micro dosed daily or every other day

TRT typically shuts down natural testosterone production

Fertility note

TRT can significantly reduce sperm production

Sometimes managed with:

human chorionic gonadotropin (hCG)

TRT vs “cycling steroids”

TRT Steroid cycle

Medical Performance use

Stable hormone levels Supraphysiological levels

Long-term Short-term

Health-focused Performance-focused

TRT = replacement, not enhancement

What it’s studied for

Research commonly investigates:

reproductive endocrine signalling

testosterone regulation pathways

fertility and gonadal function models

HPG-axis modulation

pituitary hormone signalling

hypothalamic regulation mechanisms

Generally acts as a potent tumor suppressor that inhibits metastasis and tumor growth, specific to prostate cancer. Whilst it shows anti cancer effects for prostate cancer this would be the reverse for breast cancer due to the estrogen receptor negative and has shown to be pro towards Glioblastoma.

Cycle length (research / anecdotal use)

Common informal / research-style patterns

2–6 weeks frequently discussed

often used in shorter endocrine-focused protocols

Often administered:

once daily

or in intermittent pulse-style research schedules

Theoretical research schedule examples

Low protocol:

= 5 units daily (≈170 mcg)

Moderate protocol:

= 10 units daily (≈330 mcg)

Higher research example:

= 15 units daily (≈500 mcg)

Common research pairing

Often discussed alongside:

HCG

enclomiphene

gonadorelin

fertility and endocrine-focused peptide protocols

Due to overlapping reproductive hormone signalling pathways.

What it’s studied for

Research commonly investigates:

sexual arousal pathways

libido signalling

melanocortin receptor activity

CNS-mediated sexual function mechanisms

erectile function models

female sexual function research

Cycle length (research / anecdotal use)

Common informal / research-style patterns

often used as-needed in research settings

sometimes studied intermittently over 4–8 week periods

Typically not discussed as a continuous daily protocol.

Theoretical research schedule examples

Low protocol:

= 10 units as needed (≈670 mcg)

Moderate protocol:

= 15 units as needed (≈1 mg)

Higher research example:

= 30 units as needed (≈2 mg)

Common research pairing

Often discussed alongside:

Melanotan peptides

libido-focused research compounds

erectile function pathway research protocols

Due to overlapping melanocortin signalling mechanisms.

What it’s studied for

Research commonly investigates:

sleep quality pathways

recovery and relaxation signalling

stress modulation mechanisms

circadian rhythm regulation

neuroendocrine interactions

fatigue and recovery models

Cycle length (research / anecdotal use)

Common informal / research-style patterns

2–6 weeks frequently discussed

sometimes used intermittently based on sleep-focused protocols

Often administered:

nightly

typically prior to sleep-focused research periods

Theoretical research schedule examples

Low protocol:

= 5 units nightly (≈170 mcg)

Moderate protocol:

= 10 units nightly (≈330 mcg)

Higher research example:

= 15 units nightly (≈500 mcg)

Common research pairing

Often discussed alongside:

CJC-1295

Ipamorelin

recovery-focused peptide protocols

sleep and CNS-support research models

Due to overlapping recovery and restorative signalling interests.

Get smarter responses, upload files and images, and more.

What it’s studied for

NAD⁺ has become popular in aging and metabolic research.

Potential roles:

improved mitochondrial function

enhanced energy levels

support for brain function

DNA repair and longevity pathways

possible benefits in addiction recovery (studied clinically in some settings)

It interacts with:

sirtuins (linked to aging and metabolism)

Why NAD⁺ declines

Levels naturally decrease with:

aging

stress

poor metabolic health

Lower NAD⁺ is associated with:

fatigue

reduced metabolic efficiency

impaired cellular repair

Cycle length

NAD⁺ isn’t really a “cycle compound” in the traditional sense

Different forms:

1. IV / injectable NAD⁺

Often used in:

short protocols

multiple infusions

2. Oral precursors (more common)

nicotinamide riboside

nicotinamide mononucleotide

These are typically:

taken daily, long-term

not cycled

Expected effects

mild increase in energy

improved recovery feeling

subtle cognitive benefits

Important:

effects are usually subtle, not dramatic

NAD⁺ itself is biologically natural

Precursors (NR, NMN) are generally well tolerated

But:

long-term high-dose effects still being studied

IV NAD⁺ clinics vary widely in quality

Cycle length

Medically:

❌ not cycled

✅ continuous, long-term use

Performance / non-medical use:

People often talk about “cycles,” but:

common informal durations

3–6 months minimum

often 6–12+ months

Why longer?

HGH works slowly

effects take months, not weeks

HGH 100iu (100iu/3ml/300units) 3 units = 1iu

9–18 units daily

Cycle length (depends on use)

1. With TRT (ongoing use)

Not really cycled

used continuously alongside TRT

long-term protocol

2. Post-cycle therapy (PCT)

Short-term use

typically 2–4 weeks

used to restart natural production before

HCG 10000IU (10000iu/3ml/300units) 3 units = 100iu

15 units 3 x per week

Cycle length

No official global standard, but Semax is more structured than most peptides.

Common use patterns:

2–4 weeks typical

sometimes extended to:

4–6 weeks

followed by:

a break period (e.g. 1–2+ weeks)

Short cycles with breaks are commonly used

Dosing style

Usually Sub Q Inj

Taken:

Once daily

Fast-acting:

effects can be noticed within hours to days

Effects (realistic)

increased focus and mental energy

improved memory recall

smoother cognition (not jittery)

subtle mood lift

Compared to stimulants:

less “wired”

more stable and clean feeling

Cycle length

No universal standard, but commonly structured:

Typical use:

2–4 weeks

sometimes extended to:

4–6 weeks

followed by:

a break period

So:

Short cycles with breaks are standard practice

Dosing style

Sub Q Inj

Taken:

Once daily

Effects

can be felt within:

hours to days

builds gradually with consistent use

Effects (realistic)

reduced anxiety (without drowsiness)

calmer mental state

improved focus (indirectly)

better stress tolerance

Compared to medications:

not as strong as prescription anxiolytics

but fewer side effects and no sedation

Selank vs Semax (key difference)

Peptide Effect

Semax Stimulating / focus

Selank Calming / anti-anxiety

Combined use:

balances focus + calm

common in “Know blends”

What it does

Primary effect:

increases skin pigmentation (tanning)

Secondary effects (due to broader receptor activity):

increased libido

spontaneous erections (in men)

appetite suppression (mild)

Cycle length

Common informal structure:

1. Loading phase

~7–14 days

frequent dosing

goal: build baseline pigmentation

2. Maintenance phase

lower frequency dosing

used to maintain tan

Total duration:

usually 4–8 weeks

sometimes longer depending on goals

How fast it works

initial effects:

within a few days (flushing, nausea)

visible tanning:

1–3 weeks

requires:

some UV exposure for full effect

It enhances tanning, not replaces sunlight completely

Expected results

deeper, faster tan

What it’s studied for

Research commonly investigates:

oxidative stress reduction

cellular detoxification pathways

mitochondrial support mechanisms

immune system signalling

recovery and fatigue models

skin and pigmentation pathways

liver-support research applications

Cycle length (research / anecdotal use)

Common informal / research-style patterns

4–12 week protocols frequently discussed

sometimes used intermittently or continuously in antioxidant-focused research models

Often administered:

daily

or several times weekly depending on research objective

Theoretical research schedule examples

Moderate protocol:

= 25 units daily (≈100 mg)

Higher research example:

= 50 units daily (≈200 mg)

Common research pairing

Often discussed alongside:

NAD+ research compounds

mitochondrial-support peptides

recovery and detoxification-focused protocols

antioxidant and cellular resilience research models

Due to complementary oxidative stress and cellular protection pathways.

What it’s studied for

Research commonly investigates:

energy metabolism and ATP production support

nerve function and myelin maintenance

homocysteine metabolism (methylation pathways)

anemia-related physiology

cognitive performance and fatigue models

Cycle length (research / general use patterns)

Common informal / clinical-style patterns

4–12 weeks for deficiency correction models

or ongoing maintenance protocols in supplementation contexts

Often administered:

daily

or several times weekly depending on study design or deficiency severity

Vitamin B12 — 3000 mcg / 3 ml / 300 units 25 units = 250 mcg 50 units = 500 mcg

Theoretical research schedule examples

Moderate protocol:

= 25 units daily (≈250 mcg)

Higher research example:

= 50 units daily (≈500 mcg)

3000 mcg total content example longevity

25 units/day → ~12 days

50 units/day → ~6 days

Common research pairing

Often discussed alongside:

B-complex vitamins

NAD+ support protocols

metabolic and energy-focused supplementation models

recovery and fatigue-reduction research contexts

Due to overlapping roles in cellular energy and methylation pathways.